Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country.

OBJECTIVE To evaluate the long-term quality of life of patients treated for head and neck cancer at a single institution in a developing country. DESIGN Cross-sectional analysis of a consecutive series of patients. SETTING Tertiary cancer center hospital in Brazil. PATIENTS Eligible subjects included patients treated between 1974 and 1999 for head and neck carcinoma who had a minimum disease-free survival of 2 years and who completed a Portuguese version of the University of Washington Quality of Life (UW-QOL) questionnaire. MAIN OUTCOME MEASURES Descriptive analyses of the results and comparisons of the scores for each UW-QOL domain, stratified by tumor site, were performed using nonparametric tests. RESULTS Findings from 344 patients were analyzed. Of the study population, 140 (41%) had survived 2 to 5 years, 125 (36%) had survived 5 to 10 years, and 79 (23%) had survived more than 10 years since treatment. Primary tumor sites were in the oral cavity in 43.3% of cases, the oropharynx in 20.9%, the larynx in 32.0%, and the hypopharynx in 3.8%. In terms of treatment, 33.1% underwent surgery alone; 16.9%, radiotherapy alone; and 50% underwent combined treatment. Overall, 78.5% of the patients classified their own health as good or excellent. Stratified analysis showed that impairment in chewing and swallowing was more common in patients with oral and oropharyngeal tumors than in those with larynx and hypopharynx tumors, and speech impairment was more frequently related to patients with larynx and hypopharynx tumors than to those with oral and oropharynx tumors. In all tumor sites, the composite scores were significantly worse in advanced tumors than early stage tumors, but the use of combined treatment had the greatest negative impact on quality-of-life scores, after we adjusted for T and N stage with multivariable analyses (P<.001). CONCLUSIONS The Portuguese version of the UW-QOL questionnaire was an effective tool to evaluate quality of life in a Brazilian population. Although many patients reported some limitations, most reported a good to excellent long-term quality of life.

[1]  P. Gullane,et al.  Psychosocial adjustment in head and neck cancer: The impact of disfigurement, gender and social support , 2003, Head & neck.

[2]  D. Patrick,et al.  Quality-of-life outcomes in the evaluation of head and neck cancer treatments. , 2001, Archives of otolaryngology--head & neck surgery.

[3]  M. Coltrera,et al.  Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). , 2001, Archives of otolaryngology--head & neck surgery.

[4]  A. Sherman,et al.  Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). , 2000, Archives of otolaryngology--head & neck surgery.

[5]  R. Alsarraf,et al.  Quality of life in patients with head and neck cancer: lessons learned from 549 prospectively evaluated patients. , 2000, Archives of otolaryngology--head & neck surgery.

[6]  E. Vokes,et al.  How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment? , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Fayers,et al.  Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Vokes,et al.  The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity , 1996, Cancer.

[9]  E. Weymuller,et al.  Assessment of quality of life in head and neck cancer patients , 1993, Head & neck.

[10]  P. Selby,et al.  Assessing quality of life in cancer patients. , 1989, British Journal of Cancer.

[11]  C. Moinpour,et al.  Quality of life end points in cancer clinical trials: review and recommendations. , 1989, Journal of the National Cancer Institute.

[12]  L. Kowalski,et al.  Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals. , 1994, European journal of cancer. Part B, Oral oncology.

[13]  M. Morrow,et al.  Purposes and principles of staging. , 1992, Journal.